Spar-Gone: Cephalon Drops Sparlon Following "Non-Approvable" Letter

FDA also extends user fee date for Nuvigil to December to analyze safety data.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet